Jennifer Quinn
Adult Health · Brooksville, FLNPI 1538665310
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations.
Across 149 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$583
- Teva Pharmaceuticals USA, Inc.$337
- Amgen$250
- Pfizer$240
- Neurocrine Biosciences, Inc.$224
- UCB, Inc.$197
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,84697%
- Education$873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $583 |
| Teva Pharmaceuticals USA, Inc. | 17 | $337 |
| Amgen(2 entities) | 11 | $250 |
| Pfizer | 12 | $240 |
| Neurocrine Biosciences, Inc. | 13 | $224 |
| UCB, Inc. | 6 | $197 |
| Genentech USA, Inc. | 6 | $187 |
| CSL Behring | 7 | $151 |
| Biogen | 4 | $80 |
| Novartis | 4 | $79 |
| Banner Life Sciences, LLC | 3 | $66 |
| Tanabe Pharma America, Inc. | 2 | $60 |
| Eisai Inc. | 2 | $55 |
| AstraZeneca | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Acadia Pharmaceuticals Inc | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Johnson & Johnson | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $38 |
| GE HealthCare | 2 | $36 |
| Merz Pharmaceuticals, LLC | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| Livanova USA, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,934 in reported general payments places this provider in the 80th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AptiomEslicarbazepine Acetate | 20 | $24,811 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 59 | $2,284 |
| Levetiracetam | 49 | $2,006 |
| Divalproex Sodium | 12 | $1,002 |
| Carbamazepine | 20 | $905 |
| Phenytoin Sodium Extended | 18 | $568 |
| Clonazepam | 41 | $565 |
| Primidone | 15 | $532 |
| Lamotrigine | 32 | $450 |
| Gabapentin | 21 | $426 |
| Donepezil Hcl | 32 | $214 |
| Risperidone | 11 | $184 |
| Acetazolamide | 11 | $105 |
| Alprazolam | 27 | $80 |
| Tramadol Hcl | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Other adult health in Brooksville
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.